New treatments and diagnostic tools for Alzheimer's disease may be available soon, with three drugs awaiting approval and liquid biopsies being explored as a potential diagnostic tool. However, recent concerns over fraudulent images in a longstanding study have brought uncertainty to the community. There is still no effective treatment for Alzheimer's disease, and the causes beyond familial factors are unknown. Patient advocates remain optimistic, and billionaires are donating to speed up the development of diagnostic tests. Early diagnosis is key to providing a greater therapeutic window for future therapies.